Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,804 | 18,534 | 19,125 | 19,807 | 20,444 |
| Other current assets | 385 | 49 | 140 | 233 | 276 |
| TOTAL | $18,189 | $18,583 | $19,265 | $20,040 | $20,720 |
| Non-Current Assets | |||||
| PPE Net | 61 | 75 | 88 | 87 | 104 |
| Other Non-Current Assets | 125 | 147 | 170 | 12 | 12 |
| TOTAL | $186 | $222 | $258 | $99 | $116 |
| Total Assets | $18,375 | $18,805 | $19,523 | $20,139 | $20,836 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 340 | 594 | 495 | 294 | 549 |
| Accrued Expenses | 470 | 239 | 305 | 217 | 305 |
| Other current liabilities | 7 | 14 | 12 | N/A | 8 |
| TOTAL | $907 | $937 | $902 | $511 | $862 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23 | 45 | 68 | 0 | 0 |
| TOTAL | $23 | $45 | $68 | $N/A | $N/A |
| Total Liabilities | $930 | $982 | $970 | $511 | $862 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,219 | 17,219 | 17,219 | 17,219 | 17,219 |
| Common Shares | 17 | 17 | 17 | 17 | 17 |
| Retained earnings | -167,071 | -166,374 | -165,315 | -163,956 | -163,279 |
| TOTAL | $17,445 | $17,823 | $18,553 | $19,628 | $19,974 |
| Total Liabilities And Equity | $18,375 | $18,805 | $19,523 | $20,139 | $20,836 |